Company news

Edesa Biotech, Inc. news in 2020

Edesa Biotech, Inc.'s news releases, calls and decks from 2020, newest first.

View company

Edesa Biotech Issues Letter to Shareholders

December 29, 2020

Edesa Biotech Reports Fiscal Year 2020 Results

December 6, 2020

Edesa Biotech Enrolls First Patient in COVID-19 Study

November 29, 2020

Edesa Biotech to Present at H.C. Wainwright & Co. 6th Annual Israel Conference

November 5, 2020

Edesa Biotech Achieves Enrollment Milestone in Dermatitis Study

November 2, 2020

Edesa Biotech Receives Approval to Initiate COVID-19 Study in the U.S.

October 18, 2020

Edesa Biotech Reports Fiscal 3rd Quarter 2020 Results

August 11, 2020

Edesa Biotech Files IND Application for Phase 2/3 COVID-19 Study

July 29, 2020

Edesa Biotech Receives Regulatory Approval to Initiate COVID-19 Study

June 14, 2020

Edesa Biotech Reports Fiscal 2nd Quarter 2020 Results

May 14, 2020

Edesa Biotech and Light Chain Bioscience Sign License Agreement to Develop Treatments for COVID-19 Pneumonia and Other Disorders

April 19, 2020

Edesa Biotech Reports Fiscal 1st Quarter 2020 Results

February 12, 2020

Edesa Biotech Announces $4.36 million Registered Direct Offering

January 5, 2020

Decks in 2020